A phase II Trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer
The goal of this clinical research study is to learn if chemotherapy (carboplatin and paclitaxel) after surgery for endometrial cancer is better than surgery alone.
Treatment Location: N/A
IRB Review and Approval Date: 11/20/2014
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
For general questions about clinical trials: